• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Zomedica Pharmaceuticals Corp (NY: ZOM )

    0.1202 UNCHANGED
    Official Closing Price Updated: 6:30 PM EDT, Nov 1, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about Zomedica Pharmaceuticals Corp

    < Previous 1 2 3 4 5 Next >
    Zomedica Launches Ear Cytology Quick Scan Protocol for TRUVIEW(TM) Digital Microscope & Telepathology Platform
    Via ACCESSWIRE
    Zomedica to Report Third Quarter 2024 Financial Results and Provide Business Update on November 7th at 4:30 p.m. ET
    Via ACCESSWIRE
    Zomedica Announces Sponsorship of Educational Presentations at the Fetch Coastal Conference
    Via ACCESSWIRE
    Zomedica Announces Expansion of Exclusive Equine Distribution Agreement with Grovet in Europe
    Via ACCESSWIRE
    Zomedica Completes Renovation & Upgrade of Manufacturing, Distribution, and R&D Center in Plymouth, Minnesota
    Via ACCESSWIRE
    Zomedica Secures CE Mark for TRUVIEWTM Digital Microscope & Telepathology System, Expanding Global Market Opportunities
    Via ACCESSWIRE
    Zomedica's Assisi Loop(R) Product Line Designated as Fear Free(TM) Preferred Product
    Via ACCESSWIRE
    Zomedica Introduces Enhanced Audio Features for the VETGuardian(R) Zero-touch Vital Signs Remote Monitoring System
    Via ACCESSWIRE
    Zomedica Announces Key Educational Presentations at Fetch dvm360 Veterinary Conference
    Via ACCESSWIRE
    Zomedica Announces Second Quarter 2024 Financial Results: Revenue of $6.1 Million; 71% Gross Margin, and $83.0 Million in Liquidity to Support Growth
    Via ACCESSWIRE
    Zomedica Continues Global Expansion Through Strategic Partnership with SIRE Veterinario, S.A for Sales Expansion in Central America
    Via ACCESSWIRE
    Zomedica to Report Second Quarter 2024 Financial Results and Provide Business Update on August 14 at 4:30 p.m. ET
    Via ACCESSWIRE
    The United States Eventing Association Names Zomedica’s PulseVet(R) as the Official Shock Wave of the USEA
    Via ACCESSWIRE
    Zomedica Expands Global Reach Through Strategic Alliance with Leader Healthcare Group for Sales Expansion in Key International Markets
    Via ACCESSWIRE
    US Equestrian Names Zomedica’s PulseVet System as the Official Shock Wave Therapy of US Equestrian Team Veterinarians
    Via ACCESSWIRE
    Zomedica Expands TRUFORMA Addressable Market with Launch of Equine Cortisol Assay for the Platform
    Via ACCESSWIRE
    Zomedica Expands Market Opportunity for the TRUFORMA Point-of-Care Diagnostic Platform by Securing CE Mark
    Via ACCESSWIRE
    Zomedica Increases Manufacturing Capacity with Expansion of its Roswell, Georgia Facility; Can Support Production to Five times Current Levels
    Via ACCESSWIRE
    Zomedica Enhances TRUFORMA(R) Platform With Launch of Advanced Canine Cortisol Assay
    Via ACCESSWIRE
    Zomedica Publishes White Paper Highlighting Expanded Market Opportunities for PulseVet(R) Therapy
    Via ACCESSWIRE
    Sidoti Events, LLC's Virtual June Small-Cap Conference
    Via ACCESSWIRE
    Zomedica to Present at the Sidoti Small Cap Conference June 12, 2024
    Via ACCESSWIRE
    Zomedica Announces Presentation of Compelling TRUFORMA(R) Research Findings and Educational Programs at Major Veterinary Internal Medicine Conference
    Via ACCESSWIRE
    Zomedica to Present at the Lytham Partners Spring 2024 Investor Conference on May 30, 2024
    Via ACCESSWIRE
    Zomedica Releases Over-the-Air Software Update Capabilities for Its TRUFORMA(R) Platform
    Via ACCESSWIRE
    Zomedica Announces First Quarter 2024 Financial Results: Revenue up 14% to $6.3 Million; 66% Gross Margin, and $91 Million in Liquidity
    Via ACCESSWIRE
    Zomedica Expands International Reach with CE Certification for VetGuardian(R) System
    Via ACCESSWIRE
    Zomedica Strengthens Market Position with New Patents Issued for its TRUFORMA(R) Diagnostic Platform
    Via ACCESSWIRE
    Zomedica to Present at the EF Hutton Annual Global Conference on May 15, 2024
    Via ACCESSWIRE
    Zomedica Corp. (NYSE American: ZOM) Featured in Coverage of the EF Hutton Annual Global Conference
    Via Investor Brand Network
    < Previous 1 2 3 4 5 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.